Biomarkers for monitoring therapeutic side effects or various supratherapeutic confounders after kidney transplantation

W. Gong, G. H. Whitcher, N. Townamchai, X. Xiao, F. Ge

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

Although the development of novel immunosuppressants dramatically decreased the incidence of acute allograft rejection episodes, long-term allograft survival has not improved due to various postoperative confounders. These confounders include heterologous immunity by cytomegalovirus (CMV) infection, nephrotoxicity of immunosuppressants, ureteral complications, and onset of the original renal disease in the graft, which can mislead physicians from the actual diagnosis. Early and precise discrimination of these complications by using noninvasive biomarkers will benefit the patients at high-risk and be instructive in directing effective and timely therapies whenever necessary.

Original languageEnglish (US)
Pages (from-to)1265-1269
Number of pages5
JournalTransplantation Proceedings
Volume44
Issue number5
DOIs
StatePublished - Jun 2012

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Fingerprint Dive into the research topics of 'Biomarkers for monitoring therapeutic side effects or various supratherapeutic confounders after kidney transplantation'. Together they form a unique fingerprint.

Cite this